News
Veeva Systems is overvalued, with modest ~10% growth & high valuation multiples. Read why I recommend a sell rating on VEEV ...
KeyBanc lowered the firm’s price target on Veeva (VEEV) to $250 from $260 and keeps an Overweight rating on the shares. Into Q1 earnings, the ...
The company offers Veeva Commercial Cloud comprising Veeva Vault CRM Suite for pharmaceutical and biotechnology companies; Veeva Medical that provides source of medical content across multiple ...
There is veritable power in this. Enabling such a possibility is Veeva Commercial Cloud, which includes the Vault Platform, consisting of Content (PromoMats); Medical (MedComms, MedInquiry); CRM ...
While tariffs are cutting into defense stock returns, hope springs eternal with a big U.S. budget package on the way.
In our 'Marketing Excellence' themed month Sunil Ramkali discusses how to deliver an effective pharmaceutical global strategic brand plan. Developing your global strategic brand and tactical plan ...
But the wardens had other objections. “What you see now is what you saw in 1380 – there’s no way I could stick an air-source heat pump just outside the church,” said Mr Burrell. “And ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results